Weihua Xiao

Title: Weihua Xiao: Innovator in Antibody Development

Introduction

Weihua Xiao is a prominent inventor based in Hefei, China. He has made significant contributions to the field of biotechnology, particularly in the development of antibodies for therapeutic applications. His innovative work has the potential to impact cancer treatment and improve patient outcomes.

Latest Patents

Weihua Xiao holds a patent for an "Antibody or antibody fragment capable of binding to lung-specific X protein and use thereof." This patent describes an antibody or antibody fragment that can bind to a lung-specific X protein, which is useful in treating tumors. The invention includes heavy chain CDRs with specific amino acid sequences and light chain CDRs that enhance its binding capabilities. The antibody is characterized as a chimeric antibody, showcasing its advanced design for therapeutic use.

Career Highlights

Throughout his career, Weihua Xiao has worked with notable organizations, including the Immunopharmaceutic Institute of Hefei Ruida Co., Ltd. and Hefei Tg Immunopharma Co., Ltd. His experience in these institutions has allowed him to refine his expertise in antibody development and therapeutic applications.

Collaborations

Weihua Xiao has collaborated with several professionals in his field, including Rui Sun and Dan Liu. These collaborations have contributed to the advancement of his research and the successful development of innovative therapeutic solutions.

Conclusion

Weihua Xiao's contributions to antibody development highlight his role as an influential inventor in the biotechnology sector. His patented work demonstrates the potential for innovative treatments in oncology, paving the way for future advancements in medical science.